NCT03291054 2024-06-11Epacadostat and Pembrolizumab in Patients With GISTColumbia UniversityPhase 2 Terminated1 enrolled 1 chart
NCT03823131 2023-05-09Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and EpacadostatUniversity of California, San FranciscoPhase 2 Terminated14 enrolled 12 charts
NCT01685255 2019-03-11A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line ChemotherapyIncyte CorporationPhase 2 Terminated83 enrolled